STRS Ohio’s Eton Pharmaceutcials ETON Stock Holding History

STRS Ohio’s Portfolio ETON Stock Details ETON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-3,800	Closed	-$20K	–	2218
2020 Q2	$20K	Buy	+3,800	New	+$18.9K	﹤0.01%	2043

Other funds holding ETON

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $36.1B AUM 19.68% 1-Year Est. Return

STRS Ohio's ETON Position: Q3 2020 in Review

STRS Ohio sold out of Eton Pharmaceutcials (ETON) in Q3 2020, closing a stake of 3,800 shares — an estimated $20K sold.

STRS Ohio first reported a position in ETON in Q2 2020 and held it in 1 quarter. The position peaked at $20K in Q2 2020. 39 funds tracked by Wall St. Rank hold ETON as of Q3 2020.

STRS Ohio reported no remaining Eton Pharmaceutcials position as of Q3 2020 after selling out during the quarter.
STRS Ohio sold 3,800 Eton Pharmaceutcials shares in Q3 2020, an estimated $20K.
STRS Ohio first reported a position in Eton Pharmaceutcials in Q2 2020 and held it in 1 quarter.
STRS Ohio's Eton Pharmaceutcials position peaked at $20K in Q2 2020.
39 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q3 2020.

Based on STRS Ohio's 13F filing for Q3 2020, filed 14 Dec 2020.